Janux Therapeutics, Inc. (JANX) Earnings Call Transcripts

7 earnings calls from July 2023 to December 1, 2025

US Health Care Biotechnology

About Janux Therapeutics, Inc.

Janux Therapeutics, Inc. (JANX) is a publicly listed company in the Biotechnology industry, within the Health Care sector. It trades and is based in US. EarningsCalls.dev maintains a free, full-text archive of its earnings call transcripts — 7 calls on record spanning July 17, 2023 to December 1, 2025. Every transcript is split into speaker-by-speaker segments with headline metrics, free to read or available through our REST API.

Earnings Call History

EarningsCalls.dev has 7 Janux Therapeutics, Inc. earnings call transcripts on record, spanning July 17, 2023 to December 1, 2025. Based on this history, Janux Therapeutics, Inc. reports semi-annually. The most recent call on file is dated December 1, 2025. The full list is below — each row opens the complete, free-to-read transcript.

Ticker
JANX
Country
US
Sector
Health Care
Industry
Biotechnology
Calls on record
7
First call
July 17, 2023
Most recent
December 1, 2025
Reporting cadence
semi-annually
Quarter Date
Shareholder/Analyst Calls Dec 1, 2025 Read transcript
Special Calls Jul 24, 2025 Read transcript
Company Conference Presentations Mar 4, 2025 Read transcript
Special Calls Dec 6, 2024 Read transcript
Special Calls Dec 2, 2024 Read transcript
Special Calls Feb 26, 2024 Read transcript
Special Calls Jul 17, 2023 Read transcript